Recent Insider Transactions - Prelude Therapeutics (NASDAQ: PRLD)

Company

Name / Role

Date

Type

Price

# Shares

Value

Balance

NASDAQ PRLD Prelude Therapeutics

Huang Jane / officer: President, CMO

07/04/2025

Sell

$0.79

3,355

$3K

80,897

NASDAQ PRLD Prelude Therapeutics

BAKER BROS. ADVISORS LP / director, 10 percent owner:

06/12/2025

Buy

$1.04

76,000

$79K

76,000

NASDAQ PRLD Prelude Therapeutics

Sandor Victor / director

06/12/2025

Buy

$1.04

38,000

$40K

38,000

NASDAQ PRLD Prelude Therapeutics

Dier Mardi / director

06/12/2025

Buy

$1.04

38,000

$40K

38,000

NASDAQ PRLD Prelude Therapeutics

FRIEDMAN PAUL A / director

06/12/2025

Buy

$1.04

38,000

$40K

38,000

NASDAQ PRLD Prelude Therapeutics

Bonita David P / director, 10 percent owner:

06/12/2025

Buy

$1.04

38,000

$40K

38,000

NASDAQ PRLD Prelude Therapeutics

Babler Martin / director

06/12/2025

Buy

$1.04

38,000

$40K

38,000